Acquisitions - Summary of the Allocation of the Fair Value of the Assets Acquired and Liabilities Assumed at the Date of Acquisition (Details) - USD ($) $ in Millions |
Mar. 31, 2025 |
Dec. 31, 2024 |
Nov. 01, 2024 |
---|---|---|---|
Business Acquisition [Line Items] | |||
Goodwill | $ 707.1 | $ 761.7 | |
Pureit | |||
Business Acquisition [Line Items] | |||
Current assets | $ 5.6 | ||
Property, plant and equipment | 0.6 | ||
Intangible assets | $ 57.4 | 57.4 | |
Goodwill | 62.9 | ||
Total assets acquired | 126.5 | ||
Current liabilities | (1.9) | ||
Net assets acquired | $ 124.6 |
X | ||||||||||
- Definition Business combination recognized identifiable assets acquired and liabilities assumed assets including goodwill. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|